| Skip to content | |||||
![]() |
|
||||
|
|
![]() |
||||||||||||
|
|
Currently, Bartron’s Med-Seg imaging device utilizes a 2-D version of Goddard’s RHSEG software to analyze digital X-rays, soft-tissue scans, mammograms, ultrasounds, MRI images, and CT scans. The RHSEG software allows Med-Seg to bring out image details that cannot be seen with the naked eye, enabling physicians to more quickly and accurately diagnose diseases and prescribe appropriate treatmenta benefit that not only can shorten pain and suffering but also can save lives. By extending the software’s capabilities to three dimensions, Bartron’s device may be able to produce a much finer detailed view of all sides of a tumor or lesion. Bartron President and CEO Fitz Walker said, “We believe this will drastically improve very early diagnosis and treatment of disease,” including breast cancer, cervical cancer, brain cancer, heart disease, osteoporosis, and periodontal diseases. Under the agreement, Goddard will develop the 3-D implementation of the software, while Bartron will develop the clinical and regulatory protocol as well as the interface for the software and hardware and other tools. (see also Increasing Efficiency of Image Processing story) |
||||||||||||
|
|||||||||||||